论文部分内容阅读
目的探讨威利坦预防和减轻包皮环切术后水肿及感染的临床价值,以降低临床包皮环切术后水肿及感染等并发症的发生率。方法将203例患者随机分为两组,对照组100例给予常规治疗,试验组103例在常规治疗基础上给予威利坦治疗,比较两组患者的疗效。结果术后两周对照组切口愈合1级占64.00%、2级占29.00%、3级占7.00%,试验组分别占85.44%、13.59%、0.97%,试验组1级愈合高于对照组,2级愈合低于对照组(P<0.05),3级愈合组间比较差异无统计学意义;对照组和试验组切口感染率为36.00%和14.56%,差异有统计学意义(P<0.05)。结论威利坦具有预防和减轻包皮环切术后组织水肿及感染的作用,值得临床推广。
Objective To investigate the clinical value of Willlitan in preventing and reducing edema and infection after circumcision to reduce the incidence of complications such as edema and infection after circumcision. Methods Totally 203 patients were randomly divided into two groups. The control group received routine therapy. 103 cases in the experimental group were treated with Willlitan on the basis of routine treatment. The curative effect was compared between the two groups. Results In the two weeks after operation, the wounds in the control group were healed in 64.00% grade 1, 29.00% in grade 2 and 7.00% in grade 3, 85.44%, 13.59% and 0.97% in test group. Grade 1 healing in test group was higher than that in control group, Grade 2 healing was lower than that of the control group (P <0.05), and there was no significant difference between the three healing groups (36.00% vs 14.56%, P <0.05) . Conclusion Willlitan can prevent and reduce tissue edema and infection after circumcision, which is worthy of clinical promotion.